Trading Options with an Edge
Select Page

EVLO

Search by
TICKER SYMBOL

Evelo Biosciences Inc

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology

7.38

0.19

(2.643%)

Volume:

96,968

52 week range:

3.82 - 19.93

Market Cap:

394.079M

Company Description:

Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAX™, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company's first product candidates are pharmaceutical preparations of single strains of microbes selected for the potential to offer defined pharmacological properties. Evelo's therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer.